Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency

This study has been terminated.
Sponsor:
Collaborator:
Children's Hospital of Pittsburgh
Information provided by:
National Center for Research Resources (NCRR)
ClinicalTrials.gov Identifier:
NCT00005098
First received: April 6, 2000
Last updated: June 23, 2005
Last verified: May 2002

April 6, 2000
June 23, 2005
March 1999
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00005098 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Study of Genotype and Phenotype in Patients With Alpha 1-Antitrypsin Deficiency
Not Provided

OBJECTIVES:

I. Establish cell lines from patients with alpha 1-antitrypsin deficiency in order to examine genetic traits that predispose to liver injury.

PROTOCOL OUTLINE:

Patients undergo blood draw and skin biopsy. Cells are isolated from patients' blood and skin, cell lines are established, and genetic traits are examined.

Observational
Primary Purpose: Screening
Not Provided
Not Provided
Not Provided
Not Provided
Alpha 1-Antitrypsin Deficiency
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
160
Not Provided
Not Provided
  • Alpha 1-antitrypsin deficiency
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00005098
199/14810, WUSM-930603
Not Provided
Not Provided
National Center for Research Resources (NCRR)
Children's Hospital of Pittsburgh
Study Chair: David H. Perlmutter Children's Hospital of Pittsburgh
National Center for Research Resources (NCRR)
May 2002

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP